Sanofi Consumer Healthcare India Share Price Target 2026 Analyst Forecast Bull and Bear Case

Sanofi Consumer Healthcare India (NSE: SANOFICONR) is a OTC Pharmaceuticals Consumer Healthcare company trading at Rs 4,618 with a market capitalisation of Rs 10,790 crore. Analysts have set the Sanofi Consumer Healthcare India share price target at Rs 5,500 for 2026, based on FY27 earnings projections and sector re-rating potential. According to Ankit Jaiswal, Senior Research Analyst at Univest, the Rs 5,500 price objective reflects improving fundamentals in the OTC Pharmaceuticals Consumer Healthcare space. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.

Click Here – Get Free Investment Predictions

Sanofi Consumer Healthcare India Share Price Target 2026: Key Takeaways

• Sanofi Consumer Healthcare India share price target 2026: Rs 5,500 (20% upside from CMP Rs 4,618)
• Bull case: Rs 6,700 | Bear case: Rs 3,700
• Ticker: SANOFICONR | Sector: OTC Pharmaceuticals Consumer Healthcare | MCap: Rs 10,790 crore
• 52W range: Rs 3,975 to Rs 5,894 | PE: 28x
• Key catalyst: Q4 FY26 results and FY27 earnings confirmation in 2026
• Key risk: FY27 earnings miss or FII outflows from Indian equities

Sanofi Consumer Healthcare India Company Overview

Sanofi Consumer Healthcare India (NSE: SANOFICONR) is a Mumbai-based Sanofi Group subsidiary manufacturing and marketing OTC healthcare products including Avomine, Combiflam, Allegra, and Nasivion brands for cough, cold, pain, and allergy categories. At CMP Rs 4,618 against a 52 week range of Rs 3,975 to Rs 5,894, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 10,790 crore with trailing PE of 28x. Compared to peers in consumer health like Abbott India and Pfizer India, Sanofi Consumer Healthcare India is positioned as a potential re-rating candidate toward the Rs 5,500 price objective on FY27 earnings delivery.

Parameter	Value
NSE Ticker	SANOFICONR
Sector	OTC Pharmaceuticals Consumer Healthcare
CMP (2026)	Rs 4,618
52 Week High	Rs 5,894
52 Week Low	Rs 3,975
Market Cap	Rs 10,790 crore
Trailing PE	28x
12-Month Analyst Target	Rs 5,500
Bull Case Target	Rs 6,700
Bear Case Target	Rs 3,700

Why Is the Sanofi Consumer Healthcare India Share Price Target Set at Rs 5,500 for 2026

FY27 Earnings Recovery and Revenue Acceleration

The Sanofi Consumer Healthcare India share price target of Rs 5,500 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Ankit Jaiswal at Univest notes that Q4 FY26 results confirming the earnings trajectory are the most direct catalyst for re-rating from CMP Rs 4,618.

Structural Sector Tailwinds in OTC Pharmaceuticals Consumer Healthcare

The OTC Pharmaceuticals Consumer Healthcare sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Sanofi Consumer Healthcare India’s position among peers in consumer health like Abbott India and Pfizer India creates a structural growth runway, with sustained outperformance being one of the key conditions for the Rs 6,700 bull case to materialise.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Sanofi Consumer Healthcare India’s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 5,500 analyst consensus.

Union Budget 2026-27 Capex Push and Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable backdrop for Sanofi Consumer Healthcare India’s OTC Pharmaceuticals Consumer Healthcare operations, improving the probability of achieving the Rs 5,500 price objective through FY27 earnings delivery.

FII Flow Normalisation After the 2026 Tariff Shock

As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 28x PE, Sanofi Consumer Healthcare India is positioned as a beneficiary of institutional reallocation toward the Rs 6,700 bull case over the medium term.

Sanofi Consumer Healthcare India Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Sanofi Consumer Healthcare India Share Price Target

Near-term support for Sanofi Consumer Healthcare India is anchored close to the 52 week low of Rs 3,975. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating from CMP Rs 4,618.

12-Month Sanofi Consumer Healthcare India Share Price Target 2026

The 12-month Sanofi Consumer Healthcare India share price target 2026 is Rs 5,500, implying approximately 20 percent upside from CMP Rs 4,618. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows.

Long Term Sanofi Consumer Healthcare India Share Price Target: FY27 to FY28

The long term Sanofi Consumer Healthcare India share price target for FY27 to FY28 is Rs 6,700 in the bull case, requiring full earnings delivery, re-rating among peers in consumer health like Abbott India and Pfizer India, and sustained institutional buying over a 2 to 3 year horizon.

Bull Case and Bear Case Scenarios for Sanofi Consumer Healthcare India in 2026

Bull Case Sanofi Consumer Healthcare India Share Price Target: Rs 6,700

The bull case Sanofi Consumer Healthcare India share price target of Rs 6,700 materialises when FY27 earnings beat analyst estimates, OTC Pharmaceuticals Consumer Healthcare tailwinds accelerate, and FII flows return strongly to Indian equities, representing approximately 45 percent potential upside from CMP Rs 4,618.

Bear Case Sanofi Consumer Healthcare India Share Price Target: Rs 3,700

The bear case Sanofi Consumer Healthcare India share price target of Rs 3,700 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of support near the 52 week low of Rs 3,975.

Scenario	Target	Key Conditions
Bull Case	Rs 6,700	FY27 beat, sector re-rating, FII inflows
Base Case (Analyst Target)	Rs 5,500	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 3,700	FY27 miss, guidance cut, FII outflows persist

Key Risks That Could Derail the Sanofi Consumer Healthcare India 2026 Price Objective

Global Macro and US Tariff Headwinds

Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the Sanofi Consumer Healthcare India share price target of Rs 5,500, with FII outflows being the direct transmission mechanism to Indian equity valuations.

FY27 Earnings Miss and Guidance Risk

An FY27 earnings miss or downward guidance revision would compress valuation multiples and is the most direct company-specific risk to the Rs 5,500 analyst price objective. Investors must monitor quarterly results and management commentary closely.

Competitive Intensity Among OTC Pharmaceuticals Consumer Healthcare Peers

Intensifying competition from peers in consumer health like Abbott India and Pfizer India could compress Sanofi Consumer Healthcare India’s market share and pricing power, a structural risk that must be weighed when assessing the defensibility of the earnings trajectory underpinning the Rs 5,500 analyst target for 2026.

Liquidity Risk and FII Selling Pressure

Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should maintain position sizing discipline and stop losses to protect capital.

How to Invest in Sanofi Consumer Healthcare India

Check the Univest Screener for live data

Before considering any investment based on the Sanofi Consumer Healthcare India share price target of Rs 5,500, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on OTC Pharmaceuticals Consumer Healthcare sector demand.

Open a Demat account with a SEBI registered stockbroker to trade Sanofi Consumer Healthcare India (NSE: SANOFICONR) with full regulatory protection. Study the competitive landscape among peers in consumer health like Abbott India and Pfizer India before executing any position.

Plan your entry using the 52 week low of Rs 3,975 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 5,500 price objective. Always set a stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio. Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Sanofi Consumer Healthcare India’s live share price and receive daily stock recommendations.

FAQs on Sanofi Consumer Healthcare India Share Price Target 2026

What is the Sanofi Consumer Healthcare India share price target for 2026?

Ans. The Sanofi Consumer Healthcare India share price target 2026 is Rs 5,500, implying approximately 20 percent upside from CMP Rs 4,618. Bull case is Rs 6,700, bear case is Rs 3,700.

What was the Sanofi Consumer Healthcare India share price target for 2025?

Ans. The 2025 price objective for Sanofi Consumer Healthcare India was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 5,500, reflecting FY27 growth potential from CMP Rs 4,618.

Is Sanofi Consumer Healthcare India a good investment at Rs 4,618?

Ans. At Rs 4,618, Sanofi Consumer Healthcare India offers potential upside toward Rs 5,500 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance. Consult a SEBI registered financial advisor before investing.

What are the key risks to the Sanofi Consumer Healthcare India share price target 2026?

Ans. Key risks to the Sanofi Consumer Healthcare India share price target of Rs 5,500 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in OTC Pharmaceuticals Consumer Healthcare. Monitoring quarterly results is essential.

What is the 52 week high and low of Sanofi Consumer Healthcare India?

Ans. The 52 week high of Sanofi Consumer Healthcare India is Rs 5,894 and the 52 week low is Rs 3,975. At CMP Rs 4,618, the stock offers potential upside toward the Rs 5,500 price objective.

What are the main growth catalysts for Sanofi Consumer Healthcare India in 2026?

Ans. Key catalysts include FY27 PAT recovery, OTC Pharmaceuticals Consumer Healthcare tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.

How does Sanofi Consumer Healthcare India compare to its peers?

Ans. Sanofi Consumer Healthcare India operates in OTC Pharmaceuticals Consumer Healthcare alongside peers in consumer health like Abbott India and Pfizer India. At CMP Rs 4,618 with MCap Rs 10,790 crore, it is a potential re-rating candidate toward the Sanofi Consumer Healthcare India share price target of Rs 5,500 on FY27 delivery.

What is the Sanofi Consumer Healthcare India share price target for 2027?

Ans. The long-term Sanofi Consumer Healthcare India share price target for FY27 to FY28 is Rs 6,700 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.